When Are Niraparib, Olaparib, and Rubraca Used for Ovarian Cancer Treatment? June 29, 2020By Amy Paturel
FDA Approves New Ovarian Cancer Maintenance Treatment: PARP Inhibitor Combination Drug Approval June 22, 2020By Jane Tungless
How to Take PARP Inhibitors for Ovarian Cancer & Minimize COVID-19 Risk June 1, 2020By Constance Costas
Bay Area Expert Explains How PARP Inhibitors Provide Hope for Ovarian Cancer May 31, 2020By Jane Tungless
